Breaking News, Collaborations & Alliances

Avacta, Cytiva Collaborate on COVID-19 Rapid Test

Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening

By: Contract Pharma

Contract Pharma Staff

Avacta Group, the developer of Affimer biotherapeutics and reagents, has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an Affimer-based point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.   The World Health Organization (WHO) recently highlighted the need for the development of rapid tests to quickly diagnose COVID-19 at point-of-care to assist in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters